In order to prevent spam,
this email address cannot be copied.
Researcher Profile - Dominic Walsh Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Community: Researcher Profiles
Researcher Profile

RESEARCHER INFORMATION
First Name:Dominic
Last Name:Walsh
Title:Associate Professor
Advanced Degrees:Ph.D.
Affiliation:Brigham & Women's Hospital
Department:Laboratory for Neurodegenerative Research
Street Address 1:Harvard Institutes of Medicine
Street Address 2:77 Avenue Louis Pasteur
City:Boston
Zip/Postal Code:02115
Country/Territory:U.S.A.
Phone:1 617 525 5059
Fax:1 617 525 5252
Email Address: 
Disclosure:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 11 October 2011]
View all comments by Dominic Walsh
Clinical Interests:
Aging Process, Prion Diseases, Tauopathies, Parkinson Disease, Alzheimer Disease
Research Focus:
Electrophysiology, Neurobiology, A-beta PP/A-beta, Protein structure/chemistry, Molecular and Cell biology, Signal transduction, Animal Models, Tau/Cytoskeleton
Work Sector(s):
Medical hospital, University
Web Sites:
Professional: www.ucd.ie
Lab: http://www.ucd.ie/conway/cv_53.html
Researcher Bio

Postdoctoral Employment

1992-1995: Postdoctoral Research Fellow in Biochemistry, The Queen's University of Belfast.
Project: "An investigation of the proteolytic cleavage of Alzheimer's APP". As a member of the research group lead by Dr. David Allsop.

1995-1998: Postdoctoral Research Fellow in Neurology. Harvard Medical School & Brigham and Women's Hospital. Project: "Fibrillogenic properties of amyloid β peptides." As a member of the groups lead by Prof. Dennis Selkoe and Dr. David Teplow.

1998: Instructor in Neurology
Harvard Medical School & Brigham and Women's Hospital

2003-2006: Wellcome Trust Senior Research Lecturer, University College Dublin.

2006-2011: Associate Professor of Neurodegeneration, University College Dublin.

2011- Associate Professor (Neurology), Brigham and Women's Hospital & Harvard Medical School.




Professional Activities

Member: Biochemical Society (1990-) and the Society for Neuroscience (1998-)
Editorial Advisor: Biochemical Journal, 2010-.

Grant reviewer: Alzheimer’s Association (USA) 1999 - 2010.
Grant reviewer: Wellcome Trust 2002, 2003, 2004, 2005 and 2006.
Grant reviewer: European Science Foundation 2004.
Grant reviewer: John Sealy Memorial Endowment Fund for Biomedical Research 2004.
Grant reviewer: Alzheimer’s Society (UK) 2004 and 2005.
Grant reviewer: Alzheimer’s Research Trust (UK) 2006.
Grant reviewer: United States-Israel Binational Science Foundation 2006.
Grant reviewer: Science Foundation Ireland 2006.
Grant reviewer: UCD Seed Funding Scheme 2006.
Committee Chair: UCD Seed Funding Scheme 2007-9.
Grant reviewer: Washington University ADRC Funding Scheme 2007.
Grant reviewer: Mayo Clinic Alzheimer’s disease Research Center Funding Scheme 2007.
Grant reviewer: Alzheimer Forschung Initiative e.V., Germany 2007.
Grant reviewer: American Health Assistance Foundation, USA 2008.
Grant reviewer: Qatar National Research Fund, Qatar 2008.
Grant reviewer: Italian Telethon Foundation 2008.
Grant reviewer: Agence Nationale de la Recherche (French National Research Agency) 2010.

Meetings correspondent: Alzheimer Research Forum 1999, 2000, 2001, 2002 and 2003. International advisory board member: Alzheimer Research Forum 2004.

Top Papers
1. Brian O'Nuallain, Darragh B. Freir, Andrew J. Nicoll, Emmanuel Risse, Neil Ferguson, Caroline E. Herron, John Collinge and Dominic M. Walsh (2010) Abeta dimers rapidly form stable synaptotoxic protofibrils. Journal of Neuroscience 30: 14411-14419.

2. Jessica M. Mc Donald, George M. Savva, Carol Brayne, Alfred T. Welzel, Gill Forster, Ganesh M. Shankar, Dennis J. Selkoe, Paul G. Ince and Dominic M. Walsh (2010) The presence of SDS-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain 133: 1297-1311.

3. Vicki Betts, Malcolm A. Leissring, Susi Keck, Georgia Dolios, Rong Wang, Dennis J. Selkoe and Dominic M. Walsh (2008) Aggregation and catabolism of disease-associated intra- Abeta mutations: reduced proteolysis of Abeta A21G by neprilysin. Neurobiology of Disease 31: 442-450.

4. Ganesh M. Shankar, Shaomin Li, Tapan H. Mehta, Amaya Garcia-Munoz, Nina E. Shepardson, Imelda M. Smith, Francesca M. Brett, Michael A. Farrell, Michael J. Rowan, Cindy A. Lemere, Ciaran M. Regan, Dominic M. Walsh, Bernardo L. Sabatini and Dennis J. Selkoe (2008) Amyloid-beta oligomers isolated directly from the brains of Alzheimer disease patients potently impair synaptic structure and plasticity and learned behavior. Nature Medicine 14:837-42.

5. Igor Klyubin, Vicki Betts, Alfred Welzel, Kaj Blennow, Henrik Zetterberg, Anders Wallin, Cynthia A. Lemere, William K. Cullen, Ying Peng, Thomas Wisniewski, Dennis J. Selkoe, Roger Anwyl, Dominic M. Walsh and Michael J. Rowan (2008) Abeta dimers in human cerebrospinal fluid disrupt synaptic plasticity: prevention by systemic passive immunization. Journal of Neuroscience 28:4231-7.

6. Dominic M. Walsh, Matthew Townsend, Marcia B. Podlisny, Ganesh M. Shankar, Julia V. Fadeeva, Omar El Agnaf, Dean M. Hartley and Dennis J. Selkoe (2005) Certain inhibitors of synthetic Abeta fibrillogenesis block oligomerization of natural Abeta and thereby rescue long term potentiation. Journal of Neuroscience 25: 2455-2462.

7. Dominic M. Walsh, Igor Klyubin, Julia V. Fadeeva, Roger Anwyl, Michael S. Wolfe, Michael J. Rowan and Dennis J. Selkoe. (2002). Naturally secreted oligomers of amyloid beta -protein potently inhibit hippocampal LTP in vivo. Nature 416: 535-539.

8. Dominic M. Walsh, Dean M. Hartley, Yoko Kusumoto, Youcef Fezoui, Aleksey Lomakin, George B. Benedek, Margret M. Condron, Dennis J. Selkoe and David B. Teplow (1999) Amyloid beta-protein fibrillogenesis: structure and biological activity of protofibrillar intermediates. Journal of Biological Chemistry 274: 25945-25952.

9. Dominic M. Walsh, Aleksey Lomakin, George B. Benedek, Margret M. Condron and David B. Teplow (1997) Amyloid betaprotein fibrillogenesis: detection of a protofibrillar intermediate. Journal of Biological Chemistry 272: 22364-22372.

10. Dominic M. Walsh, Carvell H. Williams, Hilary E. Kennedy, Gillian Murphy and David Allsop (1994) Gelatinase A not alpha-secretase? Nature 367: 27-28.
What are the top three papers (not yours) you have read recently?
Itner et al. 2010 Cell
Cisse et al. 2011 J Neuroscience
Emmanouilidou et al. 2010 J Neuroscience

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad